24/01/2003 (Agence Europe) - In a new survey carried out by the European Federation of Pharmaceutical Industries and Associations (EFPIA), Prof. Schöffski. From the University of Erlangen-Nuremberg (Germany), highlights that there are huge differences in the access to innovative medicines between the various European countries. Drawing on data collated in studies that were mainly carried out between 1997-1999, Prof. Schöffski asserts that current drug budget management in many EU countries...